Background: COPD is an umbrella diagnosis defined by obstructive lung function impairments, and is likely to be caused by a multitude of etiologies including environmental exposures, genetic predispositions and developmental factors. Molecular prediction and mechanistic modeling of COPD will therefore be essential in order to develop relevant diagnostic and treatment options for this constantly growing patient group. The availability of large-scale multi-'omics datasets and the development of computational systems medicine approaches have provided the means to elucidate global alterations in the complex etiology of COPD. Objective: To classify smoking-and COPD disease status by network-based multi-'omics data fusion analysis. We hypothesize that bridging and integration of multi-molecular level data will provide improved power for classification of smoking and COPD diagnosis. Methods: 'Omics data sets from the Karolinska COSMIC study were utilized, which includes 120 clinically well characterized subjects from 4 groups: healthy never-smokers, smokers with normal lung function, and current smoker as well as ex-smoker patients with early stage COPD (GOLD stage I-II/A-B). A network-based multi-'omics data fusion analysis was performed using unsupervised feature selection by variance networkbased multi-'omics data fusion and clustering of subjects by Similarity Network Fusion analysis. Performance was evaluated by comparison between the predicted cluster and the known groups by Normalized mutual information (NMI) within all possible 'omics combinations (n=127) and feature selection parameters (n=76). Results: We found that the prediction power was increased with the number of (complementary) 'omics data blocks used. The best predictor for all four groups (NMI=0.85) was achieved by integration of proteome, mRNA transcriptome data from BAL cells, combined with metabolomics and exosomal miRNA profiling from BAL fluid, including 276 significant COPD-influenced features (p<0.01). The corresponding average NMIs for single, double and triple 'omics integration are 0.35, 0.44 and 0.60 respectively. Smoking is a dominant factor across all the platforms, so it is easier to distinguish current smoking from non/ex-smoking subjects even with unsupervised feature selection: By integration of proteome data from BAL cells and miRNAs transcriptome from exosomes (110 features), the NMI of current smoking vs. other subjects is close to 1.0, whereas the NMIs based on the individual 'omics blocks is was 0.82 and 0.08 respectively.
